The purpose of this study is to assess the safety and effectiveness of an investigational medication cream compared to placebo (inactive substance) in the treatment of mild-to-moderate eczema.
People who have had a diagnosis of atopic dermatitis for at least 6 months and are aged 18 and older may qualify to receive study drug at no cost. There is no cost to participate, and participants will receive compensation for travel related expenses.
In order to qualify, participants must have 5%-25% of their body surface area covered in eczema, excluding their palms, soles, and scalp. This is equivalent to 5-25 palm sized patches, including fingers.
Participants will be asked to visit the study centre about 7 times over a period of about 9 weeks.
Email Tina Craig, Clinical Research Coordinator at DermEffects to register.